HENA AHSAN: Open Payments
NPI 1548742133 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 46 payments from 14 companies in 2025. Trend: 2023 $1,203 · 2024 $654 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $255 |
| Janssen Biotech, Inc. | 10 | $242 |
| QOL Medical, LLC | 7 | $156 |
| Madrigal Pharmaceuticals | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Ardelyx, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Organon LLC | 1 | $23 |
Products named: TREMFYA, Sucraid, RINVOQ, SKYRIZI, REZDIFFRA, XIFAXAN, IBSRELA, ZENPEP.
Industry payments across VA — which companies pay providers there.
